Personnel Information

写真a

UMEZAWA Yoshihiro


Job title

Assistant Professor

Graduating School 【 display / non-display

  • Hokkaido University, Faculty of Medicine, Graduated

Graduate School 【 display / non-display

  • Tokyo Medical and Dental University, Graduate School, Division of Medicine, Doctor's Course, 2017.03, Completed

Campus Career 【 display / non-display

  • 2018.04
    -
    Now
    Tokyo Medical and Dental University, Graduate School of Medical and Dental Sciences, Medical and Dental Sciences, Advanced Therapeutic Sciences, Hematology, Assistant Professor
  • 2019.11
    -
    Now
    Tokyo Medical and Dental University, Medical Hospital, Hospital Departments, Department of Internal Medicine, Hematology, Assistant Professor

Research Areas 【 display / non-display

  • Hematology

 

Published Papers & Misc 【 display / non-display

  • Nogami A, Yamamoto M, Yamamoto K, Ito M, Umezawa Y, Tohda S, Miura O, Fukuda T. Marginal zone lymphoma-like primary bone marrow lymphoma with long-term pancytopenia preceding diagnosis Rinsho ketsueki. 2020; 61 (10): 1469-1475. ( PubMed, DOI )

  • Masahide Yamamoto, Keisuke Tanaka, Yoshihiro Umezawa, Toshikage Nagao, Shigeo Toyota, Osamu Miura. Soluble Interleukin-2 Receptor Level at Diagnosis Predicts Prognosis of Patients With Follicular Lymphoma Irrespective of Initial Management Strategy. Anticancer Res.. 2019.09; 39 (9): 5115-5122. ( PubMed, DOI )

  • Kota Yoshifuji, Yoshihiro Umezawa, Ayako Ichikawa, Ken Watanabe, Osamu Miura, Masahide Yamamoto. Methotrexate-associated Classical Hodgkin Lymphoma Shows Distinct Clinicopathological Features but Comparable Clinical Outcomes With Sporadic Cases. In Vivo. 2019.09; 33 (5): 1599-1604. ( PubMed, DOI )

  • Akiyama Hiroki, Umezawa Yoshihiro, Ishida Shinya, Okada Keigo, Nogami Ayako, Miura Osamu. Inhibition of USP9X induces apoptosis in FLT3-ITD-positive AML cells cooperatively by inhibiting the mutant kinase through aggresomal translocation and inducing oxidative stress CANCER LETTERS. 2019; 453 84-94. ( PubMed, DOI )

  • Umezawa Y, Kawamata N. Novel therapies for acute myeloid leukemia based on genomic aberrations The Japanese journal of clinical hematology. 2019; 60 (6): 594-599. ( PubMed, DOI )

display all >>

Conference Activities & Talks 【 display / non-display

  • Satoru Aoyama,Shunichiro Yasuda,Daisuke Watanabe,Hiroki Akiyama,Keigo Okada,Yoshihiro Umezawa,Ayako Nogami,Osamu Miura,Norihiko Kawamata. A Protease-Mediated Regulatory Chimeric Antigen Receptor (CAR): “Double Arm” CAR System Improves Tumor-cell-Specificity of CAR-T Cell Therapy.. 62nd American Society of Hematology (ASH) annual Meeting and Exposition 2020.12.06 virtual meeting

  • Satoru Aoyama,Shunichiro Yasuda,Daisuke Watanabe,Hiroki Akiyama,Keigo Okada,Yoshihiro Umezawa,Ayako Nogami,Osamu Miura,Norihiko Kawamata. Protease harboring Chimeric Antigen Receptor (CAR) Regulates CAR-T Cell Activity. The 82nd Annual Meeting of the Japanese Society of Hematology 2020.10.10

  • Toshikage Nagao, Ayako Nogami, Yoshihiro Umezawa, Keigo Okada. COT kinase regulates cell survival and proliferation in ABC like DLBCL. The 82nd Annual Meeting of the Japanese Society of Hematology 2020.10.10

  • Daisuke Watanabe, Ayako Nogami, Keigo Okada, Hiroki Akiyama, Yoshihiro Umezawa:, Toshikage Nagao, Osamu Miura. FLT3-ITD activates RSK1 to upregulate mTORC1 and eIF4B and to inhibit BAD and BIM. The 82nd Annual meeting of Japanese Society of Hematology 2020.10.10

  • Keisuke Tanaka, Masahide Yamamoto, Satoshi Koi, Mai Kubok, Fumihiko Ouchi, Naoya Nakamura, Shigeo Toyota. High dose methotrexate for central nerve system prophylaxis in diffuse large B-cell lymphoma. The 82nd Annual Meeting of Japanese Society of Hematology 2020.10.10

display all >>